VANGUARD GROUP INC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 10:34 am Sale | 2026-03-13 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 0 0.000% | -1,574,742 (Position Closed) | Filing |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 1,574,742 7.980% | 308,367 (+24.35%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 1,266,375 7.400% | 143,314 (+12.76%) | Filing |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | VANGUARD GROUP INC | 1,123,061 6.570% | 234,643 (+26.41%) | Filing |